ArticlePathology oncology research : POR2019

Comparison of Capecitabine (Xeloda) vs. Combination of Capecitabine and Oxaliplatin (XELOX) as Neoadjuvant CRT for Locally Advanced Rectal Cancer.

Ali Yaghobi Joybari et al.PubMed ↗Publisher ↗

No numbers read from the abstract.